← Standard Biotools (LAB)

Standard Biotools SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

  • 425Nov. 19, 2026, 5:01 p.m. ETView on SEC.gov
  • 8-KNov. 19, 2026, 5 p.m. ETView on SEC.govOur explainer

    Departure/appointment of directors or officers · Submission of matters to a vote of security holders · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedStandard BioTools stockholders approve Treeline merger share issuance, 1-for-20 to 1-for-40 reverse split and Mass Cytometry sale

  • 425Nov. 16, 2026, 4:30 p.m. ETView on SEC.gov
  • 8-KNov. 16, 2026, 4:27 p.m. ETView on SEC.gov

    Other events

    AI summary, unreviewedStandard BioTools 8-K supplements Treeline merger proxy after 15 demand letters and two New York complaints; Centerview values company at $1.14 per share vs. $0.62 pre-filing market cap

  • SCHEDULE 13G/ANov. 16, 2026, 4 p.m. ETView on SEC.gov
  • 4Nov. 5, 2026, 5:36 p.m. ETView on SEC.gov
  • 10-QNov. 3, 2026, 4:45 p.m. ETView on SEC.gov
  • 425Nov. 3, 2026, 8:26 a.m. ETView on SEC.gov
  • 8-KNov. 3, 2026, 8:23 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedStandard BioTools Completes Sale of Microfluidics Business to ARCHIMED, Which Will Operate as Biomark Scientific

  • 425Oct. 5, 2026, 4:17 p.m. ETView on SEC.gov
  • 8-KOct. 5, 2026, 4:16 p.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 425Sept. 30, 2026, 5:28 p.m. ETView on SEC.gov
  • 8-KSept. 30, 2026, 5:27 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Termination of a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits

  • 4Aug. 24, 2026, 5:06 p.m. ETView on SEC.gov
  • 4Aug. 24, 2026, 5:05 p.m. ETView on SEC.gov
  • 4Aug. 24, 2026, 5:04 p.m. ETView on SEC.gov
  • SCHEDULE 13G/AAug. 14, 2026, 4:37 p.m. ETView on SEC.gov
  • SCHEDULE 13GAug. 14, 2026, 6:05 a.m. ETView on SEC.gov
  • 8-KAug. 5, 2026, 4:10 p.m. ETView on SEC.gov

    Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits

  • 10-QAug. 5, 2026, 4:10 p.m. ETView on SEC.gov
  • 4Aug. 4, 2026, 6:01 p.m. ETView on SEC.gov
  • SCHEDULE 13G/AJuly 30, 2026, 11:18 a.m. ETView on SEC.gov
  • 425July 29, 2026, 8:16 a.m. ETView on SEC.gov
  • 8-K/AJuly 29, 2026, 8:15 a.m. ETView on SEC.gov

    Financial statements and exhibits

  • 425July 28, 2026, 8:35 a.m. ETView on SEC.gov
  • 425July 28, 2026, 8:22 a.m. ETView on SEC.gov
  • 8-KJuly 28, 2026, 8:20 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits

  • 4July 27, 2026, 7:28 p.m. ETView on SEC.gov
  • 8-KJuly 24, 2026, 4:38 p.m. ETView on SEC.gov

    Delisting notice / failure to meet listing standard